Sensitivity to Purine Analogues in Childhood Leukemia Assessed by the Automated MTT-Assay
In the last two decades the survival rate of children with acute lymphoblastic leukemia (ALL) has improved greatly. However, with a complete remission percentage close to 100%, about 35% of the children still get a relapse. In a previous study it was shown that in childhood common-ALL, 5′nucleotidase (5′NT) positive cases have a poorer prognosis than 5′NT negative cases (Veerman et al., 1985). This might be due to the breakdown of the cytotoxic nucleotides of 6-MP by high cytoplasmic 5′NT activities. Alternatively, ecto 5′NT can provide purine requirements of the purine salvage pathway and therefore rescue cells from a blockage of purine de novo synthesis by 6-MP and/or MTX (Thompson, 1985; Pieters et al., 1987a). Thirdly, 5′NT positive cases might be relatively resistant to cytostatic drugs in general.
KeywordsAcute Lymphoblastic Leukemia Chronic Myeloid Leukemia Childhood Leukemia Purine Analogue Drug Sensitivity Assay
Unable to display preview. Download preview PDF.
- Edwards, N.L., Recker, D., Manfredi, J., Rembecki, R., and Fox, I.H., 1982, Regulation of purine metabolism by plasma membrane and cytoplasmic 5′nucleotidases, Am. J. Physiol., 243: C 270.Google Scholar
- Hongo, T., Fujii, Y., Mizuno, Y., Haraguchi, S., and Yoshida, T.O., 1987, Anticancer drug sensitivty test using the short-term microplate culture and MTT dye reduction assay, Jpn. J. Cancer Chemother., 14: 472.Google Scholar
- Pieters, R., Huismans, D.R., Leyva, A., and Veerman, A.J.P., 1988a, Adaptation of a rapid tetrazolium based (MTT-)assay for chemosensitivity testing in childhood leukemia, Cancer Lett., in press.Google Scholar
- Pieters, R., and Veerman, A.J.P., 1988b, The role of 5′nucleoti-dase in therapy-resistance of childhood leukemia, Med. Hypoth., in press.Google Scholar
- Skoog, L., Nordenskjold, B., Ost, A., Andersson, B., Hast, R., Giannoulis, N., Humla, S., Hgerstrom, T., Reizenstein, P., 1981, Glucocorticoid receptor concentrations and terminal trans-ferase activity as indicators of prognosis in acute non-lym-phocytic leukaemia, Br. Med. J., 282: 1826.CrossRefGoogle Scholar